Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
Resource Type
Article
Authors
Adcock, Ian M ; Azim, Adnam ; Bellamy, Mary ; Borg, Catherine ; Bourne, Michelle ; Connolly, Clare ; Costello, Richard W ; Corrigan, Chris J ; Davies, Sarah ; Davies, Gareth ; Chung, Kian F ; Gainsborough, Gabrielle ; Grandison, Traceyanne ; Hargadon, Beverley ; Horn, Avril ; Hudson, Val ; Jackson, David ; Johnston, Sebastian ; Jones, Geraldine ; McCourt, Paula ; Nunez, Maria ; Shaw, Dominic E ; Smith, Katherine ; Solis, Joel ; Stone, Roisin ; Yang, Freda ; Heaney, Liam G ; Busby, John ; Hanratty, Catherine E ; Djukanovic, Ratko ; Woodcock, Ashley ; Walker, Samantha M ; Hardman, Timothy C ; Arron, Joseph R ; Choy, David F ; Bradding, Peter ; Brightling, Christopher E ; Chaudhuri, Rekha ; Cowan, Douglas C ; Mansur, Adel H ; Fowler, Stephen J ; Niven, Robert M ; Howarth, Peter H ; Lordan, James L ; Menzies-Gow, Andrew ; Harrison, Tim W ; Robinson, Douglas S ; Holweg, Cecile T J ; Matthews, John G ; Pavord, Ian D
Source
In The Lancet Respiratory Medicine January 2021 9(1):57-68
Subject
Primary Research Articles
Language
ISSN
2213-2600